3653 results for «222»

Filter By

3653 results

The dark side of calcium: complications, crashes and comebacks

20 May 2026 – From EuroPCR 2026

Focused on the formidable challenges posed by coronary calcium, this session presents three compelling cases illustrating complications, procedural crashes, and successful recoveries. Participants learn detailed approaches to treating PCI complications related to calcified lesions and develop a skillset aimed at prevention and effective management of these...

Managing complications in STEMI: always possible?

20 May 2026 – From EuroPCR 2026

This session delves into the complexities of managing complications during STEMI interventions. Through real-world cases from Algeria, Malaysia, and Pakistan, it provides comprehensive analyses of challenging scenarios, treatment strategies, and key learnings, emphasizing the critical decision-making required to navigate complications and improve patient outcomes in high-stakes...

New strategies in STEMI treatments

20 May 2026 – From EuroPCR 2026

Investigate new strategies in STEMI treatment through data from international registries and clinical trials. This session examines the comparative efficacy of sirolimus versus paclitaxel-coated balloons, plaque modification in calcified lesions, novel cardioprotective techniques during primary PCI, and the role of AI-assisted ECG interpretation in STEMI pathways.

Bifurcation PCI with complications - Part 1

20 May 2026 – From EuroPCR 2026

This session addresses complications encountered during bifurcation PCI through real-world cases involving stent dislodgement, entrapped guidewires, failed wiring techniques, and fractured devices. It highlights technical rescue maneuvers, the role of intravascular imaging, and long-term challenges encountered in managing complex bifurcation lesions to improve procedural success and...

Bleeding and thrombotic risk in LAA closure patients

20 May 2026 – From EuroPCR 2026

This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...

The digital pulse: innovation in the cathlab

20 May 2026 – From EuroPCR 2026

This session highlights transformative innovations in the catheterization laboratory that prioritize patient-centered care and enhanced safety. Focus areas include advancements in radiation practice through new technology and the integration of artificial intelligence to improve image analysis, decision-making, and procedural efficiency in interventional cardiology.

Complex transfemoral TAVI: how to manage the root to success

20 May 2026 – From EuroPCR 2026

Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.

INOCA/ANOCA: technical aspects

20 May 2026 – From EuroPCR 2026

This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...

Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

31 Oct 2025

Nicola Ryan provides her take on the PROMISE trial presented by Rocco Antonio Montone at TCT 2025, in San Francisco.

Nicola Ryan

Author

Nicola Ryan
Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial

Impella percutaneous ventricular assist device malrotation in social media: a call to action

20 Apr 2023

The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications. 

Alessandro Beneduce

Author

Alessandro Beneduce
Luca Baldetti

Author

Luca Baldetti

Author

Anna Mara Scandroglio
Mamas Mamas

Author

Mamas Mamas
Alaide Chieffo

Author

Alaide Chieffo
Impella pVAD Malrotation in social media

The CLEAR SYNERGY (OASIS 9) Trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone versus placebo in patients with myocardial infarction

18 Nov 2024

Mirvat Alasnag provides her take on the CLEAR SYNERGY trial presented by Sanjit S Jolly at AHA 2024 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
CLEAR SYNERGY

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase
Jacob Lønborg

Author

Jacob Lønborg

Author

Ali Nazmi Calik
NOTION 3

Evidence base: A description of the key, so far published, studies in the space of drug coated balloons

23 Jan 2025

Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.

Author

Hector Garcia-Garcia
Jorge Sanz Sanchez

Author

Jorge Sanz-Sanchez
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
Didn’t find what you were looking for?